Allergan to acquire Bonti in strategic $195m deal to expand medical aesthetics pipeline
Irish pharmaceutical giant Allergan has announced its acquisition of Bonti, a U.S.-based aesthetic company specializing in fast-acting neurotoxin programs for aesthetic and therapeutic applications. The transaction, valued at $195 million, aims to solidify Allergan’s position as a leader in the expanding medical aesthetics market. Key Deal Terms and Future Payments Under the terms of the […]